CA1089448A - Process for purifying glucagon - Google Patents

Process for purifying glucagon

Info

Publication number
CA1089448A
CA1089448A CA275,504A CA275504A CA1089448A CA 1089448 A CA1089448 A CA 1089448A CA 275504 A CA275504 A CA 275504A CA 1089448 A CA1089448 A CA 1089448A
Authority
CA
Canada
Prior art keywords
glucagon
percent
column
gel
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA275,504A
Other languages
English (en)
French (fr)
Inventor
John G. Stilz
Richard L. Jackson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of CA1089448A publication Critical patent/CA1089448A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
CA275,504A 1975-12-17 1977-04-04 Process for purifying glucagon Expired CA1089448A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/641,419 US4033941A (en) 1975-12-17 1975-12-17 Process for purifying glucagon

Publications (1)

Publication Number Publication Date
CA1089448A true CA1089448A (en) 1980-11-11

Family

ID=24572291

Family Applications (1)

Application Number Title Priority Date Filing Date
CA275,504A Expired CA1089448A (en) 1975-12-17 1977-04-04 Process for purifying glucagon

Country Status (7)

Country Link
US (1) US4033941A (enExample)
CA (1) CA1089448A (enExample)
DE (1) DE2721027A1 (enExample)
FR (1) FR2389598B1 (enExample)
GB (1) GB1576344A (enExample)
NL (1) NL7703758A (enExample)
SE (1) SE443512B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4617376A (en) * 1985-07-01 1986-10-14 Eli Lilly And Company Process for recovering glucagon from pancreas glands
CA1284000C (en) * 1985-07-01 1991-05-07 David Gregory Maskalick Process for recovering glucagon from pancreas glands
EP2049149B1 (en) 2006-07-31 2015-04-15 Novo Nordisk A/S Pegylated extended insulins
EP2404934A1 (en) * 2006-09-22 2012-01-11 Novo Nordisk A/S Protease resistant insulin analogues
ES2563038T3 (es) * 2007-04-30 2016-03-10 Novo Nordisk A/S Método para secar una composición proteica, una composición proteica seca y una composición farmacéutica que comprende la proteína seca
US20100190706A1 (en) * 2007-06-01 2010-07-29 Novo Nordisk A/S Stable Non-Aqueous Pharmaceutical Compositions
ES2618073T3 (es) * 2008-03-14 2017-06-20 Novo Nordisk A/S Análogos de insulina estabilizados frente a proteasas
MX2010009850A (es) 2008-03-18 2010-09-30 Novo Nordisk As Analogos de insulina acilados y etabilizados contra proteasas.
KR20150002777A (ko) 2012-04-11 2015-01-07 노보 노르디스크 에이/에스 인슐린 제제
AU2014333979B2 (en) 2013-10-07 2018-02-15 Novo Nordisk A/S Novel derivative of an insulin analogue
MA49116A (fr) 2016-12-16 2020-03-25 Novo Nordisk As Compositions pharmaceutiques contenant de l'insuline
DK3517543T3 (da) 2018-01-30 2020-12-07 Bachem Ag Fremstilling af glucagonpeptider
CN113024658B (zh) * 2019-12-25 2022-10-21 翰宇药业（武汉）有限公司 一种纯化利拉鲁肽的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3715345A (en) * 1970-08-03 1973-02-06 Lilly Co Eli Glucagon separation process
DE2258080C3 (de) * 1972-11-27 1981-12-17 Eli Lilly And Co., Indianapolis, Ind. Verfahren zur Gewinnung von Hexatriacontapeptiden
US3878186A (en) * 1973-05-09 1975-04-15 Lilly Co Eli Process for purifying insulin
US3875138A (en) * 1973-09-27 1975-04-01 Lilly Co Eli Process for recovering glucagon

Also Published As

Publication number Publication date
US4033941A (en) 1977-07-05
GB1576344A (en) 1980-10-08
NL7703758A (nl) 1978-10-09
SE443512B (sv) 1986-03-03
FR2389598B1 (enExample) 1981-06-19
SE7705162L (sv) 1978-11-04
FR2389598A1 (enExample) 1978-12-01
DE2721027A1 (de) 1978-11-16

Similar Documents

Publication Publication Date Title
CA1089448A (en) Process for purifying glucagon
Racker [127] Glutathione reductase1 (liver and yeast)
US5028586A (en) Insulin derivatives and pharmaceutical preparations containing these derivatives
US5157021A (en) Insulin derivatives and pharmaceutical preparations containing these derivatives
US3876623A (en) Process for purifying insulin
US3907676A (en) Process for purifying insulin
NO146698B (no) Fremgangsmaate for fremstilling av et stabilt langtidsvirkende insulinprodukt
Pflumm et al. Optical Activity of Cystine-containing Proteins: III. Circular dichroism spectra of reduced and reoxidized pancreatic ribonuclease
Frieden et al. Studies of the enzyme fumarase. II. 1 Isolation and physical properties of crystalline enzyme
EP0013826A1 (en) Process for purifying insulin and insulin so prepared
AU594047B2 (en) Improvements in or relating to a process for purifying growth hormone-like materials
CN105585628A (zh) 一种甘精胰岛素的制备方法及其制备的甘精胰岛素
US4617376A (en) Process for recovering glucagon from pancreas glands
Carlson et al. Crystallization of glycerol 3-phosphate dehydrogenase, triosephosphate dehydrogenase, arginine kinase, and cytochrome c from a single extract of honeybees
Blasi et al. Thyroidal Phenylpyruvate Tautomerase: ISOLATION AND CHARACTERIZATION
CA1284000C (en) Process for recovering glucagon from pancreas glands
Rossi-Fanelli et al. Triphosphothiamine. I. Preparation and crystallization of the pure compound. Some chemical and enzymatic properties
US3687833A (en) Purification of lactogen
US3875138A (en) Process for recovering glucagon
Epand et al. Carboxyl group modification in glucagon
Ozawa Reaction of insulin with ethyl glycinate and 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide
WO1990000177A1 (en) Improved process for purifying insulin
CA1143309A (en) Apoglucose oxidase preparation
Aimoto et al. Influence of Anhydrous Hydrogen Fluoride on Hen Egg-White Lysozyme. I. Effects on Native Hen Egg-White Lysozyme
JPS63148984A (ja) α―アミラーゼインヒビターの結晶の製造方法

Legal Events

Date Code Title Description
MKEX Expiry